Bruce Booth, Director at Kymera Therapeutics, Inc. (KYMR), sold 343,635 shares at $30.02 ($10.3M) on 2022-11-02, disclosed to the SEC on 2022-11-04.
Open-market sale of $10.3M KYMR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.02 | 27,038 | $812K | 7.9% |
| 2 | $30.02 | 27,038 | $812K | 7.9% |
| 3 | $30.02 | 96,581 | $2.9M | 28.1% |
| 4 | $30.02 | 96,581 | $2.9M | 28.1% |
| 5 | $30.00 | 21,085 | $633K | 6.1% |
| 6 | $30.00 | 75,312 |
| $2.3M |
| 21.9% |
| Total | $30.01 avg | 343,635 | $10.3M | 100% |
| Filing → |
| KYMR | SELL | 2026-06-30 | $56.5M | — | Filing → |
| KYMR | SELL | 2026-06-25 | $34.8M | — | Filing → |
| KYMR | SELL | 2026-06-25 | $44.0M | — | Filing → |